BioMerieux ROA 2017-2025 | BMXMF
Current and historical return on assets (ROA) values for BioMerieux (BMXMF) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| BioMerieux ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $15.266B | $4.307B |
| bioM?rieux S.A. designs, develops, manufactures and markets systems in the field of vitro diagnostics. The company provides diagnostic solutions which determine the source of disease and contamination. It also offers solutions for managing infectious diseases, cancers and cardiovascular diseases in clinical applications. The company provides solutions for the enumeration of microbial flora, detection of specific pathogenic bacteria, monitoring of air and surface quality and sterility testing for the agri-food, cosmetics and pharmaceutical industries. bioM?rieux S.A. is based in Marcy L Etoile, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.807B | 27.32 |
| HCA Healthcare (HCA) | United States | $107.561B | 17.81 |
| CVS Health (CVS) | United States | $99.854B | 11.48 |
| Elevance Health (ELV) | United States | $69.881B | 10.25 |
| Cencora (COR) | United States | $69.843B | 22.53 |
| Natera (NTRA) | United States | $27.241B | 0.00 |
| DiDi Global (DIDIY) | China | $24.615B | 20.11 |
| Labcorp Holdings (LH) | United States | $20.446B | 15.59 |
| Medpace Holdings (MEDP) | United States | $16.681B | 41.41 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.398B | 0.00 |
| ICON (ICLR) | Ireland | $12.921B | 12.82 |
| CochLear (CHEOY) | Australia | $12.049B | 0.00 |
| Viatris (VTRS) | United States | $11.672B | 4.34 |
| Solventum (SOLV) | United States | $11.492B | 11.16 |
| Revvity (RVTY) | United States | $10.149B | 18.69 |
| Charles River Laboratories (CRL) | United States | $8.410B | 16.20 |
| HealthEquity (HQY) | United States | $7.990B | 31.98 |
| Avantor (AVTR) | United States | $7.718B | 11.79 |
| Caris Life Sciences,�Inc (CAI) | United States | $6.944B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $6.618B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $5.879B | 35.05 |
| Bausch + Lomb (BLCO) | Canada | $5.501B | 36.12 |
| Sotera Health (SHC) | United States | $4.548B | 21.93 |
| Amplifon S.p.A (AMFPF) | Italy | $4.059B | 23.68 |
| GeneDx Holdings (WGS) | United States | $3.984B | 70.41 |
| Alignment Healthcare (ALHC) | United States | $3.300B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.771B | 34.85 |
| Concentras Parent (CON) | United States | $2.398B | 14.97 |
| Premier (PINC) | United States | $2.323B | 22.51 |
| Ardent Health (ARDT) | United States | $2.069B | 7.99 |
| PACS (PACS) | United States | $1.902B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.880B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.874B | 11.19 |
| Organon (OGN) | United States | $1.744B | 1.90 |
| Progyny (PGNY) | United States | $1.549B | 30.52 |
| Teladoc Health (TDOC) | United States | $1.352B | 0.00 |
| Omada Health (OMDA) | $1.259B | 0.00 | |
| GoodRx Holdings (GDRX) | United States | $1.098B | 17.56 |
| Embecta (EMBC) | United States | $0.787B | 4.61 |
| CareDx (CDNA) | United States | $0.772B | 12.61 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 9.75 |
| Nutex Health (NUTX) | United States | $0.676B | 10.24 |
| InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
| Pomdoctor - (POM) | China | $0.616B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.587B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.536B | 0.00 |
| So-Young (SY) | China | $0.434B | 0.00 |
| CryoPort (CYRX) | United States | $0.417B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.409B | 6.14 |
| Enhabit (EHAB) | United States | $0.390B | 17.52 |
| Strata Critical Medical (SRTA) | United States | $0.380B | 0.00 |
| Oncology Institute (TOI) | United States | $0.356B | 0.00 |
| Charming Medical (MCTA) | $0.350B | 0.00 | |
| SBC Medicals (SBC) | United States | $0.320B | 7.00 |
| KindlyMD (NAKA) | United States | $0.320B | 0.00 |
| Agilon Health (AGL) | United States | $0.289B | 0.00 |
| LifeMD (LFMD) | United States | $0.249B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.228B | 0.00 |
| Beauty Health (SKIN) | United States | $0.164B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.146B | 24.99 |
| Ascend Wellness Holdings (AAWH) | United States | $0.112B | 0.00 |
| DocGo (DCGO) | United States | $0.105B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.102B | 0.00 |
| Biodesix (BDSX) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.036B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.028B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.021B | 5.78 |
| Co-Diagnostics (CODX) | United States | $0.019B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.016B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.015B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| ISpecimen (ISPC) | United States | $0.006B | 0.00 |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |